Enhancing the QUAlity and Transparency Of health Research

EQUATOR resources in German | Portuguese | Spanish

Blog Archives

09/09/2020 Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI Extension 22/06/2020 The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design 21/02/2020 Standards for reporting interventions in clinical trials of cupping (STRICTOC): extending the CONSORT statement 10/10/2019 CONSORT extension for reporting N-of-1 trials for traditional Chinese medicine (CENT for TCM): Recommendations, explanation and elaboration 02/08/2019 Checklist for the preparation and review of pain clinical trial publications: a pain-specific supplement to CONSORT 02/08/2019 CONSORT 2010 statement: extension to randomised crossover trials 26/04/2019 Reporting of Multi-Arm Parallel-Group Randomized Trials: Extension of the CONSORT 2010 Statement 24/01/2019 Reporting of stepped wedge cluster randomised trials: extension of the CONSORT 2010 statement with explanation and elaboration 24/11/2017 CONSORT-Equity 2017 extension and elaboration for better reporting of health equity in randomised trials 01/08/2017 Improving the reporting of clinical trials of infertility treatments (IMPRINT): modifying the CONSORT statement

Blog archives

Latest guest blogger

  • Why did we develop TIDieR-Placebo?

    The TIDieR reporting guideline helps authors fully report their interventions, so that they can be used by others. However, TIDieR only explicitly covers active interventions, not placebo controls. The developers of the new TIDieR-Placebo extension explain why it is needed Read More